Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

2014-08-27 03:19:56 | BioPortfolio


The investigators intend to show that DDAVP improves platelet activity from baseline to 30-60 minutes after treatment.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intracerebral Hemorrhage


DDAVP injection (desmopressin acetate)


Northwestern Memorial Hospital
United States


Not yet recruiting


Northwestern University

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:19:56-0400

Clinical Trials [1326 Associated Clinical Trials listed on BioPortfolio]

Desmopressin Acetate 0.2 mg Tablets, Fasting

The objective of this study was to compare the single-dose relative bioavailability of TEVA and Aventis Pharmaceuticals (DDAVP®) 0.2 mg desmopressin acetate tablets following a 0.8 mg dos...

Desmopressin in Cardiac Surgery

Patients undergoing cardiac surgery could develop excessive perioperative bleeding requiring transfusions of blood products. Desmopressin (DDAVP), already used for patients with von Wille...

Chongqing Intracerebral Hemorrhage Study

The Chongqing intracerebral hemorrhage study is a multi-center, prospective, observational study led by professor Qi Li from Chongqing Medical University. Professor Peng Xie will be the se...

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers

The purpose of this study is to determine how female hemophilia A carriers respond to a medication called DDAVP (Desmopressin).

Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage

The main purpose of this study is to determine whether deferoxamine and xingnaojing injection is effective and safe as a treatment for intracerebral hemorrhage.

PubMed Articles [3568 Associated PubMed Articles listed on BioPortfolio]

Admission Serum Calcium Level as a Prognostic Marker for Intracerebral Hemorrhage.

Prognostic significance of serum calcium level in patients with intracerebral hemorrhage is not well studied. The aim of the study was to identify if a relationship between admission serum calcium lev...

Quantitative proteomic analysis of intracerebral hemorrhage in rats with a focus on brain energy metabolism.

Intracerebral hemorrhage (ICH) is a lethal cerebrovascular disorder with a high mortality and morbidity. The pathophysiological mechanisms underlying ICH-induced secondary injury remain unclear.

Role of Xingnaojing combined with naloxone in treating intracerebral haemorrhage: A systematic review and meta-analysis of randomized controlled trials.

Xingnaojing injection (XNJ) sharpen the mind and induce consciousness and are widely used in acute phases of intracerebral hemorrhage (ICH). Naloxone hydrochloride injection (NX) performs equally well...

Heart rate variability is associated with outcome in spontaneous intracerebral hemorrhage.

Autonomic imbalance as measured by heart rate variability (HRV) has been associated with poor outcome after stroke. Observations on HRV changes in intracerebral hemorrhage (ICH) are scarce. Here, we a...

Venous Thromboembolism in Patients With Spontaneous Intracerebral Hemorrhage: A Multicenter Study.

Patients with spontaneous intracerebral hemorrhage (ICH) are predisposed to venous thromboembolic (VTE) complications, such as deep vein thrombosis and pulmonary embolism.

Medical and Biotech [MESH] Definitions

A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.

An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC

Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.

Treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels.

More From BioPortfolio on "Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept"

Quick Search


Searches Linking to this Trial